Anywhere Dx, a company focused on making diagnostic testing more accessible, has secured $291K in a recent crowdfunding round. The startup is developing an affordable platform that combines molecular science with user-centered design, aiming to simplify high-quality diagnostics for use in home and near-patient settings.
This capital infusion, supported by investors including NSF and NIH, will help Anywhere Dx advance its mission to reduce delays and uncertainty in getting health answers. The company's flexible platform is designed to support multiple health needs over time, expanding access to timely information and improving outcomes for individuals and care teams.

















